3650 Capital
Funding Round in 2025
3650 Capital is a CRE lending and loan servicing firm.
Imepac
Acquisition in 2025
Imepac offers medical courses and programs that builds knowledge and transform lives.
Deel
Secondary Market in 2025
Deel, Inc., also known as Lets Deel, Inc., is a payroll and compliance platform that simplifies the hiring and management of global remote contractors. Founded in 2017 and headquartered in San Francisco, California, the company offers an integrated platform that combines contracts, payments, and tax compliance into a single interface. This allows businesses to efficiently manage the complexities of hiring international employees while ensuring adherence to local regulations. Deel's services include automated payment processing, invoicing, customer support, and insurance products related to employment. The platform is designed to enhance the experience for both organizations and contractors, streamlining the onboarding process and facilitating seamless payroll operations worldwide.
Auron Therapeutics
Series B in 2025
Auron Therapeutics, Inc. is a biotechnology company based in Wellesley, Massachusetts, founded in 2018. The company is dedicated to developing innovative therapies for cancer, aiming to shift the traditional focus from merely killing cancer cells to transforming malignant cells into normal, functioning cells through a process known as differentiation therapy. This approach seeks to reactivate the body's innate cellular programs, promoting tumor cell maturation and the restoration of normal tissue. Auron Therapeutics leverages advanced platforms that integrate large genomic datasets and utilize high-throughput flow cytometry to efficiently identify and validate potential drug targets in primary human patient samples. Through its research, the company aims to address significant unmet medical needs in oncology, ultimately striving to deliver life-saving and transformative treatments for cancer patients.
Light Horse Therapeutics
Series A in 2025
Light Horse Therapeutics is a biotechnology company specializing in the application of gene editing to small-molecule drug discovery. It develops innovative methods to target the root causes of severe and life-threatening diseases, with an initial focus on challenging oncology targets. The company's advanced platform identifies critical functional domains within disease-related proteins, enabling the development of more effective therapies.
Tenvie Therapeutics
Series A in 2025
Tenvie Therapeutics is a biotechnology company founded to improve patients' lives with neurological, cardiometabolic, and ophthalmic diseases. The company is focused on developing small molecules targeting brain inflammation, metabolic dysfunction, and lysosomal issues, with a robust pipeline inherited from Denali Therapeutics. Tenvie is progressing a range of therapeutics aimed at addressing neurological, cardiometabolic, and ophthalmic conditions. Its collection of fully owned, highly brain-penetrant, and precisely designed peripherally restricted small molecules targets three main factors of disease: alleviating inflammation, correcting metabolic dysfunction, and rejuvenating lysosomal function.
Al Ittihad Drug Store
Acquisition in 2024
Al Ittihad Drug Store is a distributor specializing in pharmaceutical and consumer healthcare products, catering primarily to pharmacies and supermarkets. The company provides a diverse array of therapeutic classes, including medications for antibacterial needs, hypertension, diabetes, cardiovascular health, and anticoagulants, along with medical devices and various consumer products. By focusing on the comprehensive healthcare needs of consumers, Al Ittihad Drug Store ensures timely deliveries, extensive network coverage, competitive pricing, and tailored services to its clients.
Global Medical Supply Chain
Acquisition in 2024
Global Medical Supply Chain is a healthcare logistics company specializing in the supply of medical consumables. It offers a range of services, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance, to ensure a reliable and efficient medical product supply chain. The company's portfolio comprises medical supplies, logistics services, warehouse management, and comprehensive medical supply chain solutions, aiming to deliver sustainable value and competitive advantages to its clients.
nChroma Bio
Venture Round in 2024
nChroma Bio is a biotechnology company specializing in targeted genetic medicine. It operates an integrated product engine for safe, accurate, and targeted in vivo administration, aiming to overcome limitations of current genetic medicine techniques. The company focuses on liver-targeted therapies, initially for chronic hepatitis B and D, leveraging epigenetics to enable precise and specific gene regulation. This approach allows for therapies with programmable tissue specificity, potentially offering durable and targeted cures for the liver and other organs.
Silver Rock Financial
Private Equity Round in 2024
Silver Rock Financial LP is an employee-owned asset management firm established in December 2015, with its headquarters in Los Angeles, California, and additional offices in New York, Miami, and Santa Monica. The firm specializes in investment management services for pooled investment vehicles, charitable organizations, corporations, and family investment vehicles. Silver Rock employs an opportunistic credit strategy, focusing on global investments in stressed, distressed, and performing credit across the full capital structure, including leveraged loans and high-yield bonds. The firm utilizes fundamental analysis and in-house research to guide its investment decisions and also offers mutual funds to its clients. As a Registered Investment Adviser, Silver Rock Financial is committed to delivering tailored investment solutions.
Zelis
Private Equity Round in 2024
Zelis is a healthcare and financial technology company that specializes in claims cost management and payments optimization solutions. Founded in 2016 and based in Bedminster, New Jersey, Zelis provides integrated services such as network analytics, payment integrity, electronic payments, and claims communications. These offerings aim to streamline the pricing, payment, and explanation of healthcare claims for payers, healthcare providers, and consumers across medical, dental, and workers' compensation markets. By leveraging advanced technology, Zelis assists its clients in navigating the complexities of the healthcare financial landscape while ensuring compliance with evolving regulations. The company is supported by investment firms Parthenon Capital Partners and Bain Capital.
9fin Limited is a London-based company founded in 2016 that specializes in developing artificial intelligence software designed to provide comprehensive financial data for the bond market, particularly focusing on high-yield bonds. The company offers a data analytics platform that utilizes computer vision and machine learning to facilitate the search, filtering, and analysis of financial information. By delivering real-time market news, deal monitoring, and price data presented in chart formats, 9fin supports professionals in finance, investment banking, and asset management in making informed investment decisions. Its tools foster collaboration among teams and assist users in assessing risks effectively, ultimately streamlining the decision-making process in the credit markets.
CI Financial
Acquisition in 2024
CI Financial is an independent firm specializing in wealth and asset management services for both individuals and institutions. The company has a significant presence in the Canadian market, ranking as the second-largest non-bank affiliated asset manager, with substantial assets under management and advisement. CI Financial is known for its adaptive approach to meet the evolving needs of investors, offering a diverse range of investment strategies and services aimed at enhancing client experiences. By combining personalized service with the resources and expertise of a larger organization, CI Financial strives to provide a distinctive wealth management experience that sets it apart in the industry.
Odoo
Secondary Market in 2024
Odoo is an open-source platform that offers a comprehensive suite of integrated business applications tailored for various operational needs of companies. Its software encompasses tools for customer relationship management (CRM), eCommerce, accounting, inventory management, point of sale, and project management, among others. The applications are designed to function cohesively, enabling seamless workflows across different departments. By facilitating automation and tracking capabilities, Odoo empowers businesses to manage their operations efficiently from any device, making it a versatile solution for organizations of all sizes.
Crusoe Energy Systems
Series D in 2024
Crusoe Energy Systems Inc., based in Denver, Colorado, develops innovative technology and solutions aimed at addressing operational, environmental, and regulatory challenges in the oil and gas sector. Founded in 2018, the company specializes in its Digital Flare Mitigation solution, which allows upstream operators without pipeline access to convert wasted natural gas into electricity for energy-intensive computing. This service not only helps oil and gas producers reduce routine flaring of natural gas but also assists them in achieving regulatory compliance and maintaining production levels amid increasing regulations and pipeline constraints. Crusoe Energy Systems is committed to creating solutions that benefit the environment, local communities, and energy producers alike.
GC Therapeutics
Series A in 2024
GC Therapeutics is a biotechnology company focused on the programming of patient-derived stem cells into various cell types using synthetic biology. The company has developed a proprietary platform that integrates synthetic biology and artificial intelligence, allowing for efficient and scalable cell programming. Their technology enables the creation of customized cells, known as SuperCells™, tailored for specific medical conditions. With a foundation rooted in research from Professor George Church's lab at Harvard Medical School, GC Therapeutics aims to streamline the manufacturing process of unique cell therapies while enhancing cell quality and efficiency. The company is composed of a team of biologists and tissue engineers committed to advancing this innovative approach to improve patient outcomes.
Flink
Venture Round in 2024
Flink is a Berlin-based company founded in 2020 that specializes in an online platform for grocery delivery services. The company offers a diverse range of grocery products, including fresh herbs, fruits, bread, and essential home supplies. Flink's application allows customers to receive their orders within ten minutes, providing a convenient solution for acquiring everyday necessities while maintaining supermarket pricing. By focusing on quick delivery and a broad selection of items, Flink aims to enhance the shopping experience for consumers seeking efficiency and convenience in their grocery purchasing.
UCB Pharma
Acquisition in 2024
UCB Pharma is a subsidiary of Union Chimique Belge that specializes in neurology and allergies.
Yondr Group
Private Equity Round in 2024
Yondr Group is a developer, owner-operator, and service provider of hyper-scale data centers that caters to the increasing data capacity requirements of technology companies. The company specializes in designing, delivering, and operating large-scale data center facilities worldwide. Yondr Group focuses on providing cost-effective solutions tailored to meet the specific needs of its clients, offering custom-built rack-ready spaces to accommodate diverse technical real estate demands. Through its comprehensive approach, Yondr Group addresses the complexities of data center capacity while ensuring efficient service delivery.
Outpace Bio
Series B in 2024
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.
FirstVet, established in 2016 and based in Stockholm, Sweden, operates as a digital veterinary clinic. It offers video consultations with veterinarians, accessible via mobile application or website, for a wide range of pets including small animals, farm animals, and horses. Services encompass medical advice, feeding guidance, tick protection, and behavioral counseling. The platform aims to provide convenient, cost-effective, and timely veterinary care to pet owners.
Stake is a digital platform that facilitates real estate investment, allowing individuals to invest in income-generating rental properties quickly and easily. The platform aims to modernize real estate investment by making it accessible to a broader audience. Stake achieves this by breaking down properties into smaller, investable shares, thereby enabling users to purchase stakes in residential properties. This approach not only democratizes real estate investment but also enhances transparency and profitability for investors. Through its innovative model, Stake provides a streamlined way for individuals to engage in the real estate market without the complexities traditionally associated with property investment.
Storyblok
Series C in 2024
Storyblok GmbH is a software-as-a-service (SaaS) company based in Linz, Austria, that operates a cloud-based content management platform designed to facilitate content creation and management. Founded in 2015, Storyblok provides an open component composing system that enables users to upload, manage, and publish content through its robust APIs. The platform distinguishes itself by offering highly customizable content blocks and visual editing tools, which enhance usability for content editors while maintaining flexibility for developers. Key features of Storyblok's system include a visual composer, diverse content types, custom field types, and extensive API endpoints, particularly for e-commerce applications. This functionality empowers content creators to edit and manage content independently, without requiring coding skills, thus streamlining the content production process across various use cases.
RelyOn Nutec
Acquisition in 2024
RelyOn Nutec specializes in safety and survival training for the Oil & Gas, Maritime, Offshore Wind, and other high-risk sectors. The company focuses on preventing accidents and injuries by providing comprehensive training in safe conduct, survival skills, competence management, and crisis management. In addition to in-person training sessions, RelyOn Nutec also offers a variety of online courses through its website, catering to the needs of employees in industries that require a heightened emphasis on safety. By equipping clients with essential safety knowledge and skills, RelyOn Nutec helps organizations prioritize employee well-being and operational safety.
Fortress Investment Group
Acquisition in 2024
Fortress Investment Group, established in 1998, is a global investment management firm headquartered in New York. It specializes in alternative asset management, offering a wide range of investment strategies including private equity, credit, liquid markets, and traditional asset management. Fortress caters to over 1,500 institutional investors and private clients worldwide, leveraging its deep experience and specialized expertise. The firm's diverse portfolio spans various sectors such as commercial products, food and beverages, information technology, financial services, transportation, energy, infrastructure, and healthcare.
Arbol is a company that operates a climate risk assessment and insurance platform aimed at helping businesses mitigate financial losses from extreme weather events. It connects weather-exposed agricultural entities with capital providers, such as insurers and asset managers, through its innovative insurance marketplace. By utilizing big data, artificial intelligence, and blockchain technology, Arbol enhances transparency and efficiency in managing climate risks. The platform offers parametric insurance solutions that eliminate information asymmetry and lower administrative costs by using objective data from satellites and weather stations. This enables automated pricing and instant payouts based on predefined data triggers, allowing businesses across various sectors to access capital from non-insurance sources and effectively manage their climate-related financial challenges.
Metsera is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for obesity and metabolic conditions. The company focuses on advancing a variety of treatment options, including both oral and injectable therapies, specifically targeting incretin, non-incretin, and combination approaches. By integrating proprietary health technology tools, Metsera aims to provide personalized care that meets the evolving demands of weight loss treatment. Its commitment to addressing multiple therapeutic targets positions the company to significantly impact the future of obesity management and related metabolic diseases.
Flip is a social shopping app that merges the dynamics of social media with e-commerce, enabling customers to discover beauty products through video reviews. The platform allows users to share their preferences and experiences, receiving clothing items tailored to their likes and interactions. In this innovative environment, the traditional fitting room is transformed into a virtual space where users can try on products at home and share their looks with friends for feedback. Flip facilitates a community-driven shopping experience, where shoppers can access user-generated content, engage with video reviews, and benefit from peer validation before making purchases. This approach enhances the shopping journey by combining social engagement with instant access to a marketplace.
Avanse Financial Services
Private Equity Round in 2024
Avanse Financial Services Limited is a Mumbai-based non-banking finance company that specializes in education financing for students in India. Established in 1992, the company provides a range of loan products tailored to different educational needs, including higher education loans for studies both in India and abroad, e-learning loans for vocational training, and institutional loans for educational institutions. Avanse Financial Services aims to make education financing accessible and affordable, offering financial solutions that cover course fees and living expenses without imposing a cap on loan amounts. By leveraging technology, the company ensures a seamless borrowing experience, supporting students from pre-school through post-graduation and contributing to the overall growth of the education sector. As a subsidiary of Olive Vine Investment Limited, Avanse Financial Services continues to focus on empowering deserving students to achieve their academic aspirations.
KELIX Bio
Acquisition in 2024
KELIX Bio is a biopharmaceutical company that specializes in the development and distribution of high-complexity generic medicines, targeting underserved populations in emerging markets, particularly in Egypt and North Africa. The company focuses on differentiated therapeutic areas, including oncology, and aims to enhance the availability and affordability of essential pharmaceuticals in these regions. By leveraging innovation and cost leadership, KELIX Bio seeks to address the challenges faced by healthcare systems in providing access to critical medications, ultimately improving health outcomes for patients in its markets.
Capstan Therapeutics
Series B in 2024
Capstan Therapeutics is a biotechnology company focused on advancing precision in vivo cell engineering to create therapeutics for various disease categories that have unmet or underserved clinical needs. The company specializes in expanding the therapeutic potential of RNA-based therapies through proprietary targeted delivery systems. Their platform utilizes targeted lipid nanoparticles to enhance off-the-shelf immunotherapies, providing tight control over dosage and activity of engineered cells. This approach aims to develop transformative products for conditions such as oncology, fibrosis, and inflammation-related diseases.
Moove is a mobility fintech company focused on providing revenue-based vehicle financing to mobility entrepreneurs across Africa. By leveraging embedded alternative credit-scoring technology, Moove integrates its services within ride-hailing, logistics, and last-mile delivery platforms. This innovative approach allows the company to assess the performance and revenue of mobility entrepreneurs, enabling it to underwrite loans for individuals who have been historically excluded from traditional financial services. Through its unique model, Moove aims to democratize vehicle ownership and enhance access to financial resources for a growing number of mobility operators in the region.
Truist Insurance Holdings
Private Equity Round in 2024
Truist Insurance Holdings is a subsidiary of Truist Financial Corporation and the sixth-largest insurance brokerage.
Unlearn.AI
Series C in 2024
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.
Manipal Hospitals
Secondary Market in 2024
Manipal Hospitals, part of the Manipal Education and Medical Group, is a prominent player in India's healthcare sector, particularly recognized in South India. With a legacy spanning over five decades, it has evolved into the country's third largest healthcare group, operating a network of 15 hospitals and three primary clinics. The organization offers a wide range of multi-specialty healthcare services that cater to both Indian and international patients. Its comprehensive care includes both curative and preventive services, addressing medical issues from minor ailments to complex health challenges. Manipal Hospitals is dedicated to providing quality and affordable healthcare, making it a significant contributor to the healthcare landscape in India and beyond.
Ciitizen
Seed Round in 2023
Ciitizen Corporation is a healthcare technology company based in Palo Alto, California, that operates a digital platform designed to empower patients to collect, organize, and share their personal health information, including genomic data and lab results. Founded in 2017, Ciitizen aims to give individuals control over their complete health records, facilitating the sharing of this information with caregivers, researchers, and other relevant parties. The platform addresses the limitations of existing health data portals, which often provide only minimal information and rely on labor-intensive processes to extract insights from unstructured data. By normalizing diverse health information into actionable formats, Ciitizen enhances transparency and accessibility for patients and healthcare providers alike. The company is led by CEO Anil Sethi and is supported by a prominent investment team.
Andalusia Labs
Series A in 2023
Andalusia Labs is focused on creating foundational digital infrastructure tailored for internet markets, particularly in the realm of digital assets. The company develops a comprehensive risk management infrastructure that includes a security platform and a risk management marketplace. This infrastructure is designed to assist the blockchain market in effectively managing substantial amounts of digital assets, thereby supporting innovative companies worldwide. Through its offerings, Andalusia Labs aims to enhance the security and stability of digital asset transactions and management.
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.
Atvos
Secondary Market in 2023
Atvos Agroindustrial S.A. is a Brazilian company based in São Paulo that specializes in the production and commercialization of ethanol, very high polarity (VHP) sugar, and electricity derived from sugarcane biomass. Founded in 2007 and formerly known as Odebrecht Agroindustrial S.A., Atvos offers both anhydrous and hydrous ethanol, positioning itself as a provider of sustainable and renewable energy solutions. The company is currently undergoing reorganization and operates as a subsidiary of State Street Brasil S.A. - Banco Comercial. Through its focus on utilizing sugarcane and biomass, Atvos aims to contribute to cleaner and more responsible energy production.
Rejuveron Life Sciences
Series B in 2023
Rejuveron Life Sciences AG is a biotechnology company based in Zug, Switzerland, founded in 2019. The company focuses on developing and investing in innovative drugs and technologies aimed at promoting healthy aging and extending lifespan. As a fully integrated platform, Rejuveron combines its investment strategies with a commitment to advancing therapies that address age-related conditions, leveraging both scientific research and entrepreneurial initiatives in the life sciences sector.
Aman Resorts
Private Equity Round in 2023
Aman Resorts is a luxury hotel and destination management company known for its intimate and discreet guest experiences. The brand operates small resorts, hotels, and villas situated in beautiful natural locations, ensuring exclusivity and privacy for its guests. Each property features a limited number of rooms and offers a range of services that include accommodations, dining, spa facilities, tours, and access to cultural activities. Aman’s philosophy emphasizes creating sanctuaries that transcend conventional luxury, as exemplified by Aman New York, which uniquely integrates urban living with exclusive features such as private swimming pools and expansive outdoor spaces. The company also facilitates rentals and bookings through its online portal, enhancing accessibility to its distinguished offerings.
Getir, established in 2015, is a technology company based in Istanbul, Turkey. It specializes in on-demand delivery services, focusing on fast-moving consumer products such as groceries, household items, and personal care products. The company operates in major Turkish cities like Istanbul, Izmir, Ankara, Bursa, and Kocaeli. Getir's mobile application allows users to browse and purchase products, track their deliveries in real-time, and make secure mobile payments.
Moove
Private Equity Round in 2023
Moove is a mobility fintech company focused on providing revenue-based vehicle financing to mobility entrepreneurs across Africa. By leveraging embedded alternative credit-scoring technology, Moove integrates its services within ride-hailing, logistics, and last-mile delivery platforms. This innovative approach allows the company to assess the performance and revenue of mobility entrepreneurs, enabling it to underwrite loans for individuals who have been historically excluded from traditional financial services. Through its unique model, Moove aims to democratize vehicle ownership and enhance access to financial resources for a growing number of mobility operators in the region.
Georgiamune
Series A in 2023
Georgiamune is a biotechnology company specializing in immunotherapy for cancer treatment. It develops advanced immunotherapeutic and homeostatic therapies aimed at enhancing the body's natural defenses against cancer, with the goal of improving patient recovery times.
Aligned
Private Equity Round in 2023
Aligned Data Centers is a leading technology infrastructure company offering innovative, sustainable, and adaptive Scale Data Centers and Build-to-Scale solutions for global hyperscale and enterprise customers. Our intelligent infrastructure allows densification and vertical growth within the same footprint, enabling customers to scale up without disruption, all while maintaining industry-leading Power Usage Effectiveness (PUE). By reducing the energy, water and space needed to operate, our data center solutions, combined with our patented cooling technology, offer businesses a competitive advantage by improving sustainability, reliability, and their bottom line.
EpiBiologics
Series A in 2023
EpiBiologics is a biotechnology company focused on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. Utilizing its proprietary EpiTAC platform, EpiBiologics creates therapeutics designed to degrade these disease-driving proteins, addressing the underlying biology of a wide range of disorders. The company's innovative approach enables researchers to manipulate cellular proteostasis, offering potential advancements in the treatment of challenging health conditions.
CoolIT Systems
Acquisition in 2023
CoolIT Systems Inc., based in Calgary, Canada, specializes in designing, engineering, and manufacturing direct contact liquid cooling technologies for data centers, servers, and desktops. The company offers a variety of cooling solutions, including CPU and GPU coolers, liquid-to-liquid heat exchanges, liquid-to-air heat exchanges, and all-in-one liquid CPU coolers. Its products cater to high-performance computing, cloud, and enterprise markets, serving industries such as finance, oil and gas, research, and big data. CoolIT Systems focuses on delivering next-generation cooling products that meet high standards for reliability and maintenance-free operation, utilizing patented split-flow technologies to enhance rack densities, component performance, and power efficiency. The company collaborates with engineering groups, including AMD, to provide reference cooling solutions for advanced video cards. Founded in 2001, CoolIT Systems continues to innovate in the cooling technology sector both in Canada and internationally.
Matera, incorporated in 2017 and based in Paris, France, operates an online condominium management platform designed to simplify the lives of co-owners in residential properties. The platform facilitates the management of buildings by automating administrative and accounting tasks, generating necessary documents and bills based on the specific co-ownership agreements. By securely providing access to these resources online, Matera enables co-owners to independently manage their buildings without relying on traditional property management services. The company also offers legal and accounting support, further enhancing the self-management capabilities of its users.
GUODONG GROUP
Venture Round in 2023
GUODONG GROUP is involved in investment, building, operation, maintenance, and communication tower leasing services. They provide comprehensive information infrastructure services. They are engaged in constructing information infrastructure and offering communication services for business users.
TreasurySpring
Series B in 2023
TreasurySpring Limited is a financial technology firm founded in 2016 and headquartered in London, United Kingdom. The company operates an online platform designed to connect issuers and investors in the institutional short-term funding markets. TreasurySpring offers a range of Fixed-Term Funds (FTFs) that provide access to sovereign, financial, and corporate fixed-term investments. These funds enable cash-rich firms to engage in short-term investments that were previously difficult to access, while also allowing institutions seeking funding to tap into a wider pool of capital providers. By leveraging legal, financial, and operational technology, TreasurySpring facilitates the creation and management of these financial instruments, enhancing security and potential yields for investors.
SHEIN
Venture Round in 2023
SHEIN is an online marketplace that specializes in women's apparel, offering a wide range of fashion items including clothing, shoes, jewelry, and accessories. Founded in 2008 and headquartered in Jiangsu, China, SHEIN operates as an international B2C fast fashion e-commerce platform, serving customers in over 220 countries and regions. The company utilizes on-demand manufacturing technologies to link suppliers with an agile supply chain, effectively reducing inventory waste and allowing for the delivery of a diverse array of affordable products. By focusing on accessibility and affordability, SHEIN aims to make fashion accessible to a global audience.
TIER Mobility
Convertible Note in 2023
TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.
BrightSpeed
Private Equity Round in 2023
BrightSpeed is a broadband and telecommunications services company that serves homes and businesses. The goal of Brightspeed is to advance a society in which both individuals and organizations have access to the connectivity they require to complete important tasks. Brightspeed provides internet services without bundles, annual contracts, or data caps. The company is expanding its fiber network to improve connectivity.
Hasten
Venture Round in 2023
Hasten is a pharmaceutical manufacturing company that integrates R&D, manufacturing, and commercialization, and covers the entire industry chain. They are dedicated to creating China's innovative medical and health company, and they collaborate with key government agencies, medical and health professionals, and industry partners to provide high-quality solutions, build a health management ecosystem, and benefit more patients.
Cube Highways and Infrastructure
Private Equity Round in 2023
Cube Highways and Infrastructure is a Singapore-based company focused on investing in road and highway projects, as well as select other infrastructure sectors in India. The firm operates as an independent and professionally-managed platform, utilizing the extensive transportation experience of its management and execution teams. Cube Highways manages and invests in toll-road and highway projects, aiming to enhance India's infrastructure sustainably through improved materials and technology.
Outpace Bio
Series A in 2023
Outpace Bio is a biotechnology company that creates smart cell therapies aimed at improving efficacy and safety. It offers a platform that combines custom-designed biological functions with cellular control modalities that program the right response at the right time and place. It creates a mechanism-driven solution tailor-made to improve efficacy and safety. The company collaborates with Lyell Immunopharma to develop and commercialize a potential immune cell therapy for the treatment of cancer, auto-immune diseases, infectious diseases, degenerative diseases, regenerative medicine, metabolic disorders, and genetic disorders, enabling healthcare providers to cure a wide range of diseases as per patient's need.
EpiBiologics
Series A in 2023
EpiBiologics is a biotechnology company focused on developing antibody-based targeted therapies aimed at membrane and extracellular proteins that contribute to various diseases. Utilizing its proprietary EpiTAC platform, EpiBiologics creates therapeutics designed to degrade these disease-driving proteins, addressing the underlying biology of a wide range of disorders. The company's innovative approach enables researchers to manipulate cellular proteostasis, offering potential advancements in the treatment of challenging health conditions.
JD Digits
Series B in 2023
JD Digits, a subsidiary of JD.com, is a technology company that bridges the financial and physical industries. It offers digital solutions such as supply chain finance, consumer finance, insurance, and securities. The company's platform leverages data technology, AI, IoT, and blockchain to provide secure, high-yield, customized financial services and investment management for both individual and business users. Additionally, JD Digits operates JD Digital Insurance, which offers online loan and insurance solutions.
Chroma Medicine
Series B in 2023
Chroma Medicine is a genomic medicine company founded in 2021 and based in Cambridge, Massachusetts, specializing in epigenetic editing. The company is pioneering a new class of genomic therapies aimed at revolutionizing the treatment of genetically driven diseases. By utilizing epigenetics, which is the natural mechanism for gene regulation, Chroma Medicine develops programmable epigenetic editors that target specific genes and modulate chromatin conformation. This innovative approach enables healthcare providers to achieve precise control of gene expression, offering a promising therapeutic option for conditions linked to genetic anomalies.
TIER Mobility
Venture Round in 2023
TIER Mobility GmbH is a Berlin-based shared micro-mobility provider founded in 2018, specializing in electric kick scooters, e-bikes, and e-mopeds for local commuting. The company aims to transform urban mobility by offering users a convenient way to access light electric vehicles through its application software, which allows them to locate and book available scooters. TIER is dedicated to promoting climate neutrality and reducing urban dependence on cars, contributing to a more sustainable and livable environment. Through its proprietary Energy Network, TIER strives to enhance the efficiency and accessibility of its services, thereby supporting cities in their efforts to improve mobility solutions.
Truist Insurance Holdings
Secondary Market in 2023
Truist Insurance Holdings is a subsidiary of Truist Financial Corporation and the sixth-largest insurance brokerage.
Precision Neuroscience
Series B in 2023
Precision Neuroscience, founded in 2021 and based in New York, develops next-generation brain-computer interface technology aimed at treating neurological illnesses. The company's platform is designed to be minimally invasive and safely removable, with the capability to process large amounts of data. This technology enables direct connection between the human brain and artificial intelligence, offering potential breakthrough treatments for the one billion patients worldwide affected by neurological conditions.
Paradigm is rebuilding the clinical research ecosystem by developing a platform that allows all patients equitable access to trials while improving trial efficiency and lowering barriers to participation for healthcare providers. It is an innovative company that is dedicated to transforming the clinical research ecosystem. Their mission is to create a more accessible and equitable healthcare system by developing a platform that enables patients from diverse backgrounds to participate in clinical trials. Clinical trials are essential for testing and developing new drugs, therapies, and medical devices, but historically, they have been plagued by inefficiencies, barriers to access, and inequities in patient representation. Paradigm aims to solve these challenges by creating a platform that uses technology and data-driven insights to streamline the clinical trial process, making it more efficient, cost-effective, and inclusive. The Paradigm platform is designed to facilitate seamless communication and collaboration among all stakeholders involved in clinical research, including patients, healthcare providers, pharmaceutical companies, and regulatory agencies. By leveraging technology such as AI, machine learning, and predictive analytics, Paradigm can identify and match eligible patients to clinical trials, streamline the recruitment and enrollment process, and provide real-time data insights to all stakeholders. Overall, Paradigm's innovative approach to clinical research has the potential to revolutionize the healthcare industry by improving patient outcomes, reducing healthcare costs, and accelerating the development of new treatments and therapies.
Tabby Inc. is a financial technology company based in the United Arab Emirates that offers innovative payment solutions for online and offline shopping. The company specializes in a buy now, pay later service, providing consumers in the UAE and Saudi Arabia with flexible payment options. Customers can choose to pay for their purchases either in a single deferred payment or in multiple installments, allowing them to manage their spending and enhance their shopping experience. Through its platform, Tabby aims to reshape the relationship between consumers and money, promoting financial freedom and responsible spending.
Dental Care Alliance
Acquisition in 2023
Dental Care Alliance, LLC, based in Sarasota, Florida, offers comprehensive dental support services to dental practices across several states, including Florida, Georgia, Illinois, Indiana, Maryland, Michigan, Pennsylvania, and Virginia. Founded in 1991, the company provides a range of management services designed to alleviate the administrative burdens faced by dental professionals. These services include financial management, billing, recruiting, marketing, and staff training, enabling dentists to focus more on patient care and less on day-to-day operations. By promoting clinical autonomy and enhancing career satisfaction, Dental Care Alliance supports both the professional growth of dental teams and the overall well-being of patients. The company operates various Dental Centers, providing tailored management and administrative support to ensure efficient practice operations.
Resilience
Private Equity Round in 2023
Resilience, established in 2020 and headquartered in La Jolla, California, is a biopharmaceutical manufacturing and technology company. It specializes in providing end-to-end manufacturing and development solutions for complex medicines, including biologics, vaccines, nucleic acids, and cell and gene therapies. Resilience invests in developing new manufacturing technologies to ensure rapid, safe, and scalable production, thereby enhancing patient access to these treatments. The company partners with biopharmaceutical companies to focus on breakthrough discoveries while Resilience manages the manufacturing process, safeguarding supply chains against future disruptions.
Upstream Health
Series B in 2023
Upstream Health is a company based in North Lincolnshire, United Kingdom, that specializes in developing innovative technologies and service approaches for health and social care teams. Founded in 2018, the company utilizes artificial intelligence alongside a mobile and analytics platform to promote a proactive, "upstream" approach to healthcare, focusing on preventive care. Upstream Health's platform is designed to enhance electronic medical record systems, enabling health and social care professionals to improve patient outcomes through comprehensive clinical functions. By integrating experienced technologists and health service innovators, Upstream Health aims to address the evolving needs of the health and social care systems, ultimately improving citizen health outcomes.
ACTIVE Al Maryah
Venture Round in 2023
ACTIVE Al Maryah is a sports and recreation company that focuses on building and managing comprehensive indoor and outdoor sports facilities. It operates a multi-sport complex that caters to a variety of activities, including football, padel, and tennis. By providing well-maintained and efficiently managed sports environments, ACTIVE Al Maryah aims to promote a healthy lifestyle and encourage community engagement in sports and recreation throughout the year. The company emphasizes exceptional service and the creation of spaces that support physical activity and well-being for individuals of all ages.
ACX
Convertible Note in 2022
AirCarbon Exchange, based in Singapore, operates a blockchain-based platform designed for trading carbon commodities, including carbon credits generated by various mitigation projects. The exchange facilitates both spot and futures markets, catering to industry stakeholders managing their carbon liabilities. Supported by the Sustainable Energy Association of Singapore and the Digital Exchange Association, AirCarbon tokenizes carbon offsets into three distinct asset classes: the AirCarbon CORSIA Token for offsets compliant with ICAO guidelines, the AirCarbon Forestry Token for offsets from forest management projects, and the AirCarbon Premium Token for high-quality offsets that align with the United Nations Millennium Development Goals. Additionally, AirCarbon manages an investment fund that provides development capital to carbon sequestration initiatives, generating liquidity in the carbon market and enhancing trading volume. The platform aims to streamline trading processes and support the transition to a carbon-constrained economy while contributing to verified projects that reduce atmospheric carbon.
Vevo Therapeutics
Seed Round in 2022
Vevo Therapeutics is a biotechnology startup focused on improving drug discovery through its Mosaic in vivo drug discovery platform and advanced AI algorithms. The company aims to enhance treatment options for a broader patient population by integrating in vivo data with artificial intelligence to identify more effective drug targets. This innovative approach captures the in vivo context of diseases with single-cell precision, addressing the limitations of traditional in vitro assays. By better representing patient diversity in drug responses, Vevo Therapeutics seeks to reduce the failure rate of drugs in clinical trials, ultimately leading to more successful therapeutic outcomes.
UpStream Care
Series B in 2022
UpStream Care is a primary care services and technology company providing physicians with support and systems. It allows physicians to focus on what they and their patients value the most. Their intelligent technology platform, which integrates with all physician EMRs and provides an elegant workflow for all care coordination activities, augments this in-person clinical support.
ACX
Private Equity Round in 2022
AirCarbon Exchange, based in Singapore, operates a blockchain-based platform designed for trading carbon commodities, including carbon credits generated by various mitigation projects. The exchange facilitates both spot and futures markets, catering to industry stakeholders managing their carbon liabilities. Supported by the Sustainable Energy Association of Singapore and the Digital Exchange Association, AirCarbon tokenizes carbon offsets into three distinct asset classes: the AirCarbon CORSIA Token for offsets compliant with ICAO guidelines, the AirCarbon Forestry Token for offsets from forest management projects, and the AirCarbon Premium Token for high-quality offsets that align with the United Nations Millennium Development Goals. Additionally, AirCarbon manages an investment fund that provides development capital to carbon sequestration initiatives, generating liquidity in the carbon market and enhancing trading volume. The platform aims to streamline trading processes and support the transition to a carbon-constrained economy while contributing to verified projects that reduce atmospheric carbon.
Ramp Network
Series B in 2022
Ramp Network is a fintech startup founded in 2017 by Przemek Kowalczyk and Szymon Sypniewicz, headquartered in Warsaw, Poland. The company focuses on developing payment infrastructure that bridges the gap between cryptocurrency and traditional finance. Its mission is to create a seamless connection between the open blockchain financial system and conventional banking, eliminating the need for a trusted third party. Ramp Network's platform is designed for a variety of clients, including enterprises, gaming companies, non-fungible token marketplaces, decentralized finance projects, and digital wallets. This integration enables these businesses to facilitate fiat-to-crypto transactions for their users, allowing for efficient contract execution and the locking of digital assets within their operations.
Juvena Therapeutics
Series A in 2022
Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company focuses on developing protein-based therapeutics aimed at promoting tissue rejuvenation, primarily targeting age-related conditions such as sarcopenia, wound healing, and neural regeneration. Juvena Therapeutics utilizes a drug discovery platform that screens for restored cellular functions to create innovative therapeutics that facilitate tissue regeneration and repair. By decoding secreted proteins, the company aims to address various chronic and rare diseases, ultimately enhancing the quality of life for elderly patients.
Recursion Pharmaceuticals
Post in 2022
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in Salt Lake City, Utah, that focuses on revolutionizing drug discovery through the integration of advanced technologies such as artificial intelligence, automation, and bioinformatics. Founded in 2013, the company has developed a comprehensive drug discovery platform that includes various tools and software, such as ReChem for chemical compound design, ReScreen for managing complex experimental workflows, and RePredict for modeling drug relationships using machine learning. These innovations enable Recursion to generate extensive biological and chemical datasets, facilitating the exploration of foundational biology and accelerating the development of new therapeutic solutions. Through its unique approach, Recursion aims to significantly enhance patient outcomes and streamline the drug discovery process.
TruFoodMfg
Acquisition in 2022
TruFoodMfg specializes in contract manufacturing, focusing on private-label nutrition bars, protein bars, chocolate molded products, and baked goods. The company serves a diverse clientele by distributing its products through various retail channels, including club stores, grocery outlets, drug stores, convenience stores, and department stores across the globe.
GlobalConnect
Secondary Market in 2022
GlobalConnect is a prominent alternative provider of fiber network, data center, and managed hosting services in Northern Europe, primarily focusing on Denmark and Germany. Established in 1998 by Niels Zibrandtsen, the company operates a 12,500 km optical fiber network and manages approximately 13,000 square meters of data center space. GlobalConnect offers a range of services including bandwidth connectivity, colocation, and cloud infrastructure, catering to both enterprises and consumers. With a workforce of over 200 employees, the company is dedicated to delivering fast and reliable networking solutions, enhancing connectivity and technological capabilities for its clients across Sweden, Norway, Denmark, Finland, and Northern Germany.
Neumora Therapeutics
Series B in 2022
Neumora Therapeutics is a clinical-stage biotechnology company focused on developing precision medicines for brain diseases by combining data science with neuroscience. Founded to address the global brain disease crisis, Neumora takes an innovative approach to treatment development. The company has established a robust therapeutic pipeline that includes seven clinical and preclinical neuroscience programs targeting novel mechanisms of action for various underserved neuropsychiatric and neurodegenerative disorders. Neumora plans to advance its pipeline further by initiating multiple clinical trials across its programs in the upcoming 12 to 18 months.
CERC Central de Recebíveis
Venture Round in 2022
CERC Central de Recebíveis S.A. is a financial services company based in São Paulo, Brazil, specializing in enhancing the utilization of receivables in credit operations. Founded in 2015 by Marcelo Maziero and Fernando Fontes, CERC has developed an intelligent platform designed to provide security and efficiency in the use of receivables as collateral for lenders. The company aims to transform the credit market by improving the security and effectiveness of credit transactions, facilitating accelerated and sustainable growth in credit offerings for businesses of all sizes.
Alloy Therapeutics
Series D in 2022
Alloy Therapeutics is a biotechnology company based in Waltham, Massachusetts, founded in 2017. The company focuses on democratizing access to essential drug discovery platforms and services, primarily through its Alloy-Gx platform. This innovative platform features a royalty-free suite of immunocompetent transgenic mice that facilitate in vivo human antibody discovery. Alloy Therapeutics has developed humanized transgenic antibody discovery technology, which offers broad, non-exclusive access to drug discovery tools, allowing scientists to engage in their antibody projects more efficiently and effectively. The company's mission is to enhance the drug discovery process by providing accessible and advanced resources for researchers in the field.
Pretzel Therapeutics
Series A in 2022
Pretzel Therapeutics is a biotechnology company focused on developing therapies for mitochondrial dysfunction. Founded by leading experts in mitochondrial biology, the company aims to address the underlying causes of mitochondrial dysfunction through a thorough understanding of mitochondrial mechanisms. By creating innovative treatments, Pretzel Therapeutics seeks to provide effective solutions for a range of diseases, particularly those related to aging. The company is dedicated to advancing the field of mitochondrial medicine and improving patient outcomes through targeted therapeutic approaches.
TruKKer is a technology-enabled truck aggregator based in Abu Dhabi, UAE, founded in 2016. The company operates a logistics and fleet management platform that simplifies road freight and logistics operations by integrating demand and supply for land freight services. TruKKer's platform connects shippers and carriers in real time, ensuring maximum utilization of available trucks and reducing overall transportation costs. The company's network, powered by real-time data analytics, enhances reliability and transparency while creating opportunities for data monetization and consolidated procurement. By offering end-to-end coverage and a comprehensive service portfolio, TruKKer facilitates cross-border transportation services for various end markets, benefiting both shippers and transporters alike.
Canada Cartage
Acquisition in 2022
Canada Cartage is a provider of outsourced fleet solutions that offers dedicated equipment and drivers to businesses of all sizes. The company specializes in trucking, warehousing, and logistics services tailored for sectors such as grocery, food, retail, and e-commerce. Its offerings include dedicated contract transportation, general freight, fulfillment, and distribution services, as well as home delivery of large format goods. By integrating managed transportation and warehousing solutions, Canada Cartage aims to address complex logistics challenges and enhance operational efficiency for its clients.
Spotnana is a travel technology company that focuses on modernizing the infrastructure of the travel industry through its innovative Travel-as-a-Service platform. This platform aims to simplify and enhance the travel experience for both corporations and consumers, making it more accessible and affordable. By transforming how travel suppliers manage and sell their inventory, Spotnana enables businesses to offer exceptional global travel experiences to their customers. The company is dedicated to fostering freedom, simplicity, and trust in travel for people around the world.
Auron Therapeutics
Series A in 2022
Auron Therapeutics, Inc. is a biotechnology company based in Wellesley, Massachusetts, founded in 2018. The company is dedicated to developing innovative therapies for cancer, aiming to shift the traditional focus from merely killing cancer cells to transforming malignant cells into normal, functioning cells through a process known as differentiation therapy. This approach seeks to reactivate the body's innate cellular programs, promoting tumor cell maturation and the restoration of normal tissue. Auron Therapeutics leverages advanced platforms that integrate large genomic datasets and utilize high-throughput flow cytometry to efficiently identify and validate potential drug targets in primary human patient samples. Through its research, the company aims to address significant unmet medical needs in oncology, ultimately striving to deliver life-saving and transformative treatments for cancer patients.
Flip is a social shopping app that merges the dynamics of social media with e-commerce, enabling customers to discover beauty products through video reviews. The platform allows users to share their preferences and experiences, receiving clothing items tailored to their likes and interactions. In this innovative environment, the traditional fitting room is transformed into a virtual space where users can try on products at home and share their looks with friends for feedback. Flip facilitates a community-driven shopping experience, where shoppers can access user-generated content, engage with video reviews, and benefit from peer validation before making purchases. This approach enhances the shopping journey by combining social engagement with instant access to a marketplace.
Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.
Wefox is a technology company specializing in the insurance sector. It operates a digital platform that connects insurance providers, brokers, businesses, and customers, facilitating access to various insurance solutions. The company focuses on indirect sales, partnering with intermediaries to expand its market reach. Wefox's platform offers services such as policy management, claims settlement, and quotation generation for a range of insurance types, including health, liability, and disability.
Klarna
Venture Round in 2022
Klarna Inc. is an e-commerce payment solutions provider that serves both merchants and consumers, specializing in flexible payment options. Founded in 2005 and headquartered in Columbus, Ohio, with additional offices in New York City, Klarna offers a range of services including direct payments, pay-after-delivery options, and installment plans. The company is recognized for its "buy now, pay later" model, allowing shoppers to finance their retail purchases with interest-free payments. Klarna also enhances the shopping experience through its app, which offers features such as cashback rewards and on-site messaging for retailers. As a regulated bank, Klarna operates under a framework that supports a variety of payment processing and dispute resolution services, aiming to make transactions simple, safe, and smooth for users.
Proximie Inc., headquartered in Bedford, Massachusetts, operates a health technology platform that facilitates remote, real-time collaboration among surgeons worldwide. The company's core service enables surgeons to virtually attend operations via augmented reality, artificial intelligence, and machine learning technologies. This allows them to visually guide complex surgeries, demonstrate techniques, and provide expertise remotely, thereby democratizing access to advanced surgical knowledge globally. Founded by Nadine Hachach-Haram in 2016, Proximie aims to enhance surgical outcomes and improve patient care through innovative telehealth solutions.
Juni is a fintech company that specializes in providing a banking app and platform tailored for e-commerce and online marketing entrepreneurs. The platform offers an integrated payment solution that allows users to manage their financial operations through a centralized dashboard, tracking all bank accounts, networks, and payment services. By delivering detailed and customizable financial reports, Juni empowers digital entrepreneurs to make informed decisions and scale their businesses effectively, ultimately enhancing their ability to thrive in the digital commerce landscape.
Medicina UniFTC
Acquisition in 2022
UniFTC Medicine is designed to train complete doctors and doctors, who will act in an efficient and humanized way, having technologies as an ally. It is Medicine transforming your future for you to transform the future of the world.
Unesulbahia
Acquisition in 2022
Unesulbahia is located in Eunápolis and currently offers nine undergraduate courses: Medicine, Biomedicine, Nursing, Pharmacy, Physiotherapy, Dietetics and Law. Unesulbahia are permanently enhanced through the Structuring Teaching Center, a group made up of 16 medical professors with renowned academic background and extensive professional experience.
Apex Group
Private Equity Round in 2022
Apex Group is a global financial services provider headquartered in Hamilton, Bermuda, founded in 2003. It offers a comprehensive range of services to asset managers, capital markets, private clients, and family offices. By continually evolving its capabilities, Apex has established itself as a single-source solution in the industry, providing services that include fund administration, digital onboarding, depositary and custody services, and business services such as human resources and payroll. The company also offers innovative ESG Ratings and Advisory services tailored for private companies. With a strong global presence, Apex Group is committed to meeting the diverse needs of its clients through a broad spectrum of products and services.
SpotOn is a technology company founded in 2017 by Doron Friedman, Matt Hyman, and Zach Hyman, headquartered in San Francisco, California. The company specializes in providing innovative software and payment solutions tailored for small and midsize businesses. SpotOn offers a comprehensive, cloud-based platform that includes tools for payments, point-of-sale systems, marketing, website development, online ordering, appointments, eCommerce, digital loyalty, and review management. By integrating these services, SpotOn aims to enhance operational efficiency and customer engagement for its clients. The company's mission is to empower businesses by delivering high-quality solutions at fair prices, supported by personalized local service.
Storyblok
Series B in 2022
Storyblok GmbH is a software-as-a-service (SaaS) company based in Linz, Austria, that operates a cloud-based content management platform designed to facilitate content creation and management. Founded in 2015, Storyblok provides an open component composing system that enables users to upload, manage, and publish content through its robust APIs. The platform distinguishes itself by offering highly customizable content blocks and visual editing tools, which enhance usability for content editors while maintaining flexibility for developers. Key features of Storyblok's system include a visual composer, diverse content types, custom field types, and extensive API endpoints, particularly for e-commerce applications. This functionality empowers content creators to edit and manage content independently, without requiring coding skills, thus streamlining the content production process across various use cases.
HiveMQ is a developer of a robust MQTT (Message Queuing Telemetry Transport) broker platform that enables businesses to connect, communicate, and manage IoT data effectively, even under real-world stress. The platform serves various industries, including automotive, energy, logistics, smart manufacturing, and transportation, offering flexibility, security, and scalability. HiveMQ's technology supports mission-critical applications, such as connected cars and IoT products, making it the trusted choice for leading brands like Audi, BMW, Honeywell, and Mercedes-Benz. By empowering organizations to modernize their operations and enhance customer experiences, HiveMQ has established itself as a standard in the enterprise IoT landscape.
Unlearn.AI
Series B in 2022
Unlearn.AI, Inc. is a biotechnology company based in San Francisco, California, that specializes in developing innovative software tools for clinical research. Established in 2017, Unlearn.AI focuses on enhancing clinical trials through its unique digital twin technology, known as TwinRCT. This approach utilizes machine learning to create prognostic digital twins for individual patients, allowing for more accurate estimations of treatment effects while reducing the number of participants needed. The company also offers services for Clinical Trial Design, which helps determine inclusion criteria, endpoints, and study sizes, as well as Synthetic Control Arms that can minimize or eliminate the need for concurrent control groups. Additionally, Unlearn.AI provides Subgroup Analysis to identify and analyze specific patient subgroups within trial results. By integrating expertise from pharmaceuticals, medical technology, and machine learning, Unlearn.AI aims to transform clinical trials to improve outcomes for both patients and sponsors.
Tata Power Renewable Energy
Post in 2022
Tata Power Renewable Energy is a Mumbai-based company focused on the development, construction, and operation of renewable energy assets, specifically in the wind and solar power sectors. Recently established as a separate entity from Tata Power, it has inherited control over 720 MW of operational capacity and has an additional 250 MW currently under construction. The company aims to enhance its portfolio through potential equity investments and acquisitions, positioning itself strategically within the renewable energy market.
Welcome Tech
Venture Round in 2022
Welcome Tech is a platform designed to support the 250 million global immigrant communities by connecting them with essential information, products, and services needed to thrive in a new environment. The company reaches over 9 million immigrants annually and has nearly 2 million active users. By utilizing a proprietary data and information engine, Welcome Tech offers tailored and relevant solutions across various sectors, including finance, education, healthcare, telecommunications, and government services. Founded by experts in immigration and technology, Welcome Tech is headquartered in Los Angeles, California, and aims to empower immigrant families to become informed and active participants in society.